| 摘要 |
Compositions comprising formononetin and/or one or more isoflavones selected from biochanin, genistein and daidzein, in a therapeutically effective ratio of formononetin to said isoflavones of 15:1 to 2:1, optionally in associatio n with one or more carriers, excipients, auxiliaries and/or diluents are described. Also described are methods of treatment involving such compositio ns including the prevention and/or treatment of cardiovascular disease, the beneficial alteration of blood lipoprotein levels, or a reduction in the ris k of vascular disease, or a reduction in the risk of coronary heart disease, o r a reduction in the risk of arteriosclerosis, or in the beneficial alteration or maintenance of bone density such as in the prevention or treatment of osteoporosis, and/or in the prevention and/or treatment of bone fracture.</S DOAB>
|
